You must be a member to access this content.
View Membership Levels
Best practices: Appropriate use of the new β-lactam/ β-lactamase inhibitor combinations, ceftazidimeavibactam and ceftolozane-tazobactam in South Africa
Guideline for Targeted Antimicrobial Treatment of CARBAPENEM RESISTANT ENTEROBACTERALES (CRE) BLOODSTREAM INFECTIONS
